11 . 05 . 2021
Glow LifeTech Reports on Additional Research Results on ArtemiC™ and Positive Implications for COVID-19 Variants
News
04 . 05 . 2021
Glow LifeTech Announces Successful First Commercial Production of ArtemiC™ for Global Distributor and a Second Production Scaled to Meet Growing Global Demand
27 . 04 . 2021
Glow LifeTech Submits Application to Health Canada for Natural Health Product Following Successful COVID-19 Phase II Clinical Trial
12 . 03 . 2021
Glow LifeTech to Commence Trading on the CSE on March 15, 2021 Under the Symbol “GLOW”
03 . 03 . 2021
Glow LifeTech Corp. Announces Completion of Business Combination
16 . 02 . 2021
Relay Medical Reports Glow LifeTech Secures Exclusive North American Rights to ArtemiC™ Following Successful COVID-19 Phase II Clinical Trial
02 . 03 . 2020
Relay Medical Announces Subsidiary Glow LifeTech has Secured Exclusive Rights for Award Winning Swiss Technology